# Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

> **NCT04149522** · PHASE2 · TERMINATED · sponsor: **Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer
- Radiotherapy; Adverse Effect, Dermatitis or Eczema
- Radiotherapy Side Effect
- Radiation Burn
- Radiation Dermatitis
- Radiotherapy; Complications

## Interventions

- **DEVICE:** Mepitel Film®

## Key facts

- **NCT ID:** NCT04149522
- **Lead sponsor:** Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-15
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-11-06
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** The mepitel film was expired and was no longer available.
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04149522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04149522, "Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04149522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*